DURYSTA J Code: J7351
Injection, bimatoprost, intracameral implant, 1 microgram
Q4 2026 Medicare Payment Limit for J7351, effective October 1, 2026: $213.795 per HCPCS billing unit, unchanged from Q3 2026. From CMS's final file.
Drug & Product Overview
About DURYSTA
Durysta is a medication aligned to the HCPCS J Code: J7351 for billing, pricing, and reimbursement purposes in the United States. It is an Orthopedic drug administered via the intracameral route and manufactured by Allergan.
According to CMS Drug Use Information: Bimatoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Lowering high pressure inside the eye can help prevent blindness. This medication may work by helping fluid inside the eye to flow out, which lowers pressure inside the eye. This implant may be placed only one time in each eye.
Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.
NDC Code Information
Based on publicly available CMS files. The list of NDCs below is not exhaustive.
| NDC Code | Drug | Manufacturer | Billing Units / Pkg | Package Size |
|---|---|---|---|---|
| 00023-9652-01 | Durysta | Allergan, Inc. | 10 | 10 UG |
DURYSTA Pricing & Reimbursement
National median reimbursement across major commercial payers.
Create an account on PayerPrice for more information →Historical Graphing and Billing Calculator
Log in to calculate billing and reimbursement with live ASP, WAC & AWP pricing.
Login to use the calculator →DURYSTA CPT Administration Codes
The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.
| CPT Code | Description |
|---|---|
| 66030 | Injection, anterior chamber of eye (separate procedure); medication |
CMS has identified Durysta (J7351) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. Wastage billing guide →
DURYSTA Medically Unlikely Edits (MUE)
The most billing units of J7351 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 1 mcg.
MAI 2 · Date of Service Edit: Policy. Absolute per-day limit set by policy or regulation; units above it are not payable, and denials are not appealable on medical-necessity grounds. See all MUE limits →
DURYSTA Clinical Information
Indications and drug classification.
This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.
Login for BuyandBill.com Analytics
Unlock deeper insights with BuyandBill’s Comparative Report!
- Compare ASP, WAC, and AWP across drugs.
- Visualize Drug Price Movement Over Time
- Tailor reports to drug class, manufacturer, or HCPCS Code.
- Compare Biosimilar and 505(b)(2) products.
Frequently Asked Questions
Is there an available Durysta billing and coding guide?
Are there any available Durysta patient assistance programs?
Where can I find Durysta prescribing information?
Where can I find Durysta side effect information?
Does billing DURYSTA require JZ/JW wastage modifiers?
About BuyandBill.com:
The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.
Related Drug Codes
Explore billing, coding, and pricing for drugs related to DURYSTA.